| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,689,511 | 1,129,521 | 488,175 | 547,166 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 1,129,521 | 488,175 | 547,166 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 568,677 | 804,439 | 668,091 | (266,931) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
| 4,013,524 | (1,989,572) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,067,999 | 325,082 | (4,193,440) | 2,803,669 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 1,204,916 | (1,204,916) | | Earnings Before Interest And Taxes | 2,103,367 | 325,082 | (2,988,524) | 1,598,753 | | Interest Expense | (50,592) | 45,382 | 83,385 | 91,368 | | Income Before Tax | 2,153,959 | 279,700 | (3,071,909) | 1,507,385 | | Income Tax Expense | (34,284) | 671,900 | (640,687) | 684,251 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,188,243 | (392,200) | (2,431,222) | 823,134 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,188,259 | (392,200) | (2,431,222) | 823,134 | | Preferred Stock And Other Adjustments | (2) | 13 |
-
|
-
| | | Net Income Applicable To Common Shares | $2,188,257 | ($392,187) | ($2,431,222) | $823,134 |
|
0.02% Nasdaq 
0.33%
Income Statement
